A3326912
Dexmedetomidine , ≥98% , 113775-47-6
CAS NO.:113775-47-6
Empirical Formula: C13H16N2
Molecular Weight: 200.28
MDL number:
EINECS: 601-281-8
Pack Size | Price | Stock | Quantity |
50MG | RMB373.60 | In Stock |
|
100mg | RMB1133.60 | In Stock |
|
250MG | RMB1839.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 146-149°C |
Boiling point: | 381.9±11.0 °C(Predicted) |
Density | 1.053±0.06 g/cm3 (20 ºC 760 Torr) |
storage temp. | Sealed in dry,Room Temperature |
solubility | Soluble in DMSO > 10 mM |
form | Powder |
pka | 13.89±0.10(Predicted) |
color | White to off-white |
InChI | InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1 |
InChIKey | CUHVIMMYOGQXCV-NSHDSACASA-N |
SMILES | C1NC([C@H](C2=CC=CC(C)=C2C)C)=CN=1 |
Description and Uses
Dexmedetomidine is a sedative drug that has many benefits when given to children under anesthesia, such as improved pain relief and reduced agitation following their surgery. The FDA-approved indications for dexmedetomidine are sedation of intubated and mechanically ventilated patients in the intensive care unit (ICU) and peri-procedural (or peri-operative) sedation of non-intubated patients.
Safety
Symbol(GHS) | GHS08,GHS07 |
Signal word | Danger |
Hazard statements | H373-H317-H360 |
Precautionary statements | P260-P314-P501-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501 |